Latest filing published 06 Feb 2026 for Phio Pharmaceuticals Corp..
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
David H. Deming, listed as board member, has filed trades across 3 companies (mainly through SEC (Form 4)), most often in Better For You Wellness, Inc., Albany Molecular Research Inc and Phio Pharmaceuticals Corp. The record holds 15 filings, for trades running from 15 June 2016 to 5 February 2026.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The newest entry dates from 6 February 2026: a share grant, in Phio Pharmaceuticals Corp. The median gap between a trade and its publication by SEC (Form 4) is 3 days. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
11 of 11 declarations